Otros idiomas Cognetivity Neurosciences Ltd.

Acciones

CGN

CA19243C1005

Diferido Canadian Securities Exchange Otros sitios de cotización 16:21:15 01/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,015 ^CAD	-25,00 %		-25,00 %	0,00 %

2023	Cognetivity Neurosciences Ltd. Resultados del tercer trimestre y nueve meses finalizados el 31 de octubre de 2023	CI
2023	Cognetivity Neurosciences Ltd. y Uc Health se asocian para mejorar la detección precoz del deterioro cognitivo en EE.UU.	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Cognetivity Neurosciences Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	29/12
CognICA(TM) Shown to Save Tens of Millions of Dollars in Healthcare Costs Annually and Improve Patient Outcomes in the UK National Health Service	24/10/23
Cognetivity Neurosciences Ltd. announced that it has received CAD 0.01 million in funding	17/10/23
Cognetivity Neurosciences Ltd. and Uc Health Partner to Improve Early Detection of Cognitive Impairment in Usa	11/10/23
Cognetivity Neurosciences and UC Health Partner to Improve Early Detection of Cognitive Impairment in USA	11/10/23
Cognetivity Neurosciences Ltd. Announces Collaboration with the Mediclinic Group	03/10/23
Cognetivity Neurosciences Announces Commercial Agreement with Mediclinic to Provide Cognitive Assessment to Over 50s	03/10/23
Cognetivity Neurosciences Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023	29/09/23
Cognetivity Neurosciences Partners with No Fear Counselling to Pioneer Brain Health Assessment Through Groundbreaking AI Technology	21/09/23
Cognetivity Neurosciences Ltd. announced that it expects to receive CAD 0.01 million in funding	15/09/23
Cognetivity Neurosciences' AI Powered CognICA Platform Wins Major Industry Award	13/09/23
Cognetivity Neurosciences Ltd. Announces Eisai's Leqembi Approval for the Treatment of Alzheimer's Disease	07/07/23
Cognetivity Neurosciences Ltd. Reports Earnings Results for the First Quarter Ended April 30, 2023	30/06/23
Clairvo Technologies, Inc. Announces Strategic Partnership with Cognetivity Neurosciences, Inc	13/06/23
Cognetivity Neurosciences Ltd. Reports Earnings Results for the Full Year Ended January 31, 2023	09/06/23
Cognetivity Neurosciences Ltd. Auditor Raises 'Going Concern' Doubt	09/06/23
Cognetivity Neurosciences Ltd. Announces Collaboration with the Alzheimer's Society to Further Expand Its AI Algorithms	31/05/23
Cognetivity Neurosciences Ltd. Announces Agreement with Mitsui Sumitomo Aioi Life Insurance of Japan to Provide CognICA Technology to Customers	25/04/23
Cognetivity Neurosciences : Announces Agreement With Japanese Life Insurance Company	25/04/23
Cognetivity Neurosciences Ltd. Appoints Karimah Es Sabar to Its Board Director	20/04/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Cognetivity Neurosciences Ltd.

Acciones

CGN

CA19243C1005

Otros idiomas

Filtros